Comparable stake leader
JANUS HENDERSON GROUP PLC
SEC ownership of Invivyd, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001832038.
Disclosed value leader
Adimab, LLC
Comparable rows
50/50
Latest evidence
31 Mar 2026
- Public ticker
- IVVD on Nasdaq
- Parsed ownership sources
-
13F, 13D/G, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
JANUS HENDERSON GROUP PLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
JANUS HENDERSON GROUP PLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
31 Mar 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001832038
- Issuer location
- New Haven, CT
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Invivyd, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
JANUS HENDERSON GROUP PLC
Disclosed value leader
Adimab, LLC
Comparable rows
50/50
Latest evidence
31 Mar 2026
13F
13D/G
3/4/5
Lead comparable stake: 12%
13D/G row: JANUS HENDERSON GROUP PLC
Showing 1-8 of 50 holder rows.
Quick read
JANUS HENDERSON GROUP PLC leads the comparable SEC ownership view at 12%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens JANUS HENDERSON GROUP PLC's linked filing trail.
Comparable ownership
Top 5
JANUS HENDERSON GROUP PLC
12%
BIOTECHNOLOGY VALUE FUND L P
9%
PERCEPTIVE ADVISORS LLC
7.9%
Adimab, LLC
7.3%
RA CAPITAL MANAGEMENT, L.P.
7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC |
13F
13D/G
Company
|
12%
from 13D/G
|
$42,857,157
33,094,330 shares
|
— | 31 Mar 2026 |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
BVF PARTNERS L P/IL
|
9%
|
$64,323,000
25,525,000 shares
|
+$24,003,000 | 31 Dec 2025 |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
Company
|
7.9%
|
$40,738,260
21,785,166 shares
|
$0 | 18 Nov 2025 |
| Adimab, LLC |
3/4/5
13D/G
10%+ Owner
|
7.3%
from 13D/G
|
$85,667,229
21,687,906 shares
|
— | 19 Jan 2024 |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
7%
|
$36,709,000
21,342,442 shares
|
-$12,925,398 | 31 Mar 2026 |
| MAVERICK CAPITAL LTD |
13D/G
13F
Company
|
6.7%
|
$47,806,701
18,970,913 shares
|
+$22,029,323 | 31 Dec 2025 |
| MITHRIL II LP |
3/4/5
13D/G
Other*, 10%+ Owner
|
4.8%
from 13D/G
|
$44,404,241
11,241,580 shares
|
— | 28 Mar 2022 |
| FMR LLC |
13D/G
13F
Company
|
4.8%
|
$3,811,862
5,775,549 shares
|
$0 | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$395,906.
Buys
$125,000
Insiders: 1
Sells
$520,906
Insiders: 5
Net
-$395,906
Shares: -454,826
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 50,000
Shares: 504,826
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 227,172 | $0 | $354,232 | -$354,232 |
| 6-9 | 50,000 | 0 | $125,000 | $0 | +$125,000 |
| 9-12 | 0 | 277,654 | $0 | $166,674 | -$166,674 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 38 reporting-owner rows connected to Invivyd, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
38
Largest Forms 3/4/5 holder
Adimab, LLC
Net 12M change
-$395,905
Latest report
19 May 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Adimab, LLC | 10%+ Owner | $85,667,229 | Filing P/S | 19 Jan 2024 | ||
| MITHRIL II LP | Other*, 10%+ Owner | $44,404,241 | Mixed | 28 Mar 2022 | ||
| Redmile Group, LLC | 10%+ Owner | $13,394,292 | Mixed | 10 Aug 2021 | ||
| Rene Russo | Director | $7,841,915 | Mixed | 05 Aug 2021 | ||
| Ajay Royan | Director | $5,008,124 | Mixed | 19 May 2026 | ||
| Cox Christopher T. | Other* | $2,685,297 | Mixed | 28 Mar 2022 | ||
| Polaris Venture Partners V, L.P. | Other* | $1,965,757 | Mixed | 28 Mar 2022 | ||
| Terrance McGuire | Director | $1,366,240 | Filing P/S | 19 May 2026 | ||
| Jill Andersen | Chief Legal Officer, Secretary | $510,598 | -$155,258 | -23% | Mixed | 15 Feb 2026 |
| Timothy Edward Lee | Chief Commercial Officer | $319,383 | -$93,158 | -23% | Mixed | 15 Feb 2026 |
| Robert D. Allen III | Chief Scientific Officer | $314,287 | -$86,173 | -22% | Mixed | 15 Feb 2026 |
| William E. Duke | Chief Financial Officer | $303,605 | -$93,158 | -23% | Mixed | 15 Feb 2026 |
| Julie Green | Chief Human Resources Officer | $303,605 | -$93,158 | -23% | Mixed | 15 Feb 2026 |
| Kevin F. McLaughlin | Director | $125,000 | +$125,000 | +100% | Filing P/S | 19 May 2026 |
| Sara Cotter | Director | $3,950 | Mixed | 21 May 2024 | ||
| Ellen R. Marram | Director | Mixed | 19 Nov 2021 | |||
| Lynn Connolly | Chief Medical Officer | Mixed | 30 Jan 2022 | |||
| Jane Pritchett Henderson | Chief Financial Officer | Mixed | 30 Jan 2022 | |||
| Anand Shah | Director | Mixed | 05 Aug 2021 | |||
| Redonda Miller | Director | Mixed | 22 Jun 2022 |
Recent insider transactions for Invivyd, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Ajay Royan | IVVD | Stock Option (Right to Buy) | Award | 50,000 | 50,000 | 19 May 2026 | Direct | |||
| Kevin F. McLaughlin | IVVD | Stock Option (Right to Buy) | Award | 50,000 | 50,000 | 19 May 2026 | Direct | |||
| Terrance McGuire | IVVD | Stock Option (Right to Buy) | Award | 50,000 | 50,000 | 19 May 2026 | Direct | |||
| Elia Marc | IVVD | Stock Option (Right to Buy) | Award | 50,000 | 50,000 | 19 May 2026 | Direct | |||
| Marc Elia | IVVD | Stock Option (Right to Buy) | Award | 50,000 | 50,000 | 19 May 2026 | Direct | |||
| Paul Bolno | IVVD | Stock Option (Right to Buy) | Award | 32,876 | 32,876 | 19 May 2026 | Direct | |||
| Tamsin Berry | IVVD | Stock Option (Right to Buy) | Award | 50,000 | 50,000 | 19 May 2026 | Direct | |||
| Robert D. Allen III | IVVD | Common Stock | Sale | -14.5% | $30,597 | $1.58 | -19,392 | 114,487 | 18 Feb 2026 | Direct |
| Julie Green | IVVD | Common Stock | Sale | -16.3% | $33,077 | $1.58 | -20,964 | 107,717 | 18 Feb 2026 | Direct |
| William E. Duke | IVVD | Common Stock | Sale | -16.3% | $33,077 | $1.58 | -20,964 | 107,717 | 18 Feb 2026 | Direct |
| Timothy Edward Lee | IVVD | Common Stock | Sale | -15.1% | $33,077 | $1.58 | -20,964 | 117,717 | 18 Feb 2026 | Direct |
| Jill Andersen | IVVD | Common Stock | Sale | -16.1% | $55,127 | $1.58 | -34,939 | 181,736 | 18 Feb 2026 | Direct |
| Robert D. Allen III | IVVD | Common Stock | Sale | -12% | $28,004 | $1.54 | -18,189 | 133,879 | 17 Feb 2026 | Direct |
| Julie Green | IVVD | Common Stock | Sale | -13.3% | $30,273 | $1.54 | -19,663 | 128,681 | 17 Feb 2026 | Direct |
| William E. Duke | IVVD | Common Stock | Sale | -13.3% | $30,273 | $1.54 | -19,663 | 128,681 | 17 Feb 2026 | Direct |
| Timothy Edward Lee | IVVD | Common Stock | Sale | -12.4% | $30,273 | $1.54 | -19,663 | 138,681 | 17 Feb 2026 | Direct |
| Jill Andersen | IVVD | Common Stock | Sale | -13.1% | $50,454 | $1.54 | -32,771 | 216,675 | 17 Feb 2026 | Direct |
| Robert D. Allen III | IVVD | Common Stock | Options Exercise | 186.6% | 99,000 | 152,068 | 15 Feb 2026 | Direct | ||
| Robert D. Allen III | IVVD | Restricted Stock Units | Options Exercise | -49.2% | -99,000 | 102,000 | 15 Feb 2026 | Direct | ||
| Julie Green | IVVD | Common Stock | Options Exercise | 200.6% | 99,000 | 148,344 | 15 Feb 2026 | Direct | ||
| Julie Green | IVVD | Restricted Stock Units | Options Exercise | -49.2% | -99,000 | 102,000 | 15 Feb 2026 | Direct | ||
| William E. Duke | IVVD | Common Stock | Options Exercise | 200.6% | 99,000 | 148,344 | 15 Feb 2026 | Direct | ||
| William E. Duke | IVVD | Restricted Stock Units | Options Exercise | -49.2% | -99,000 | 102,000 | 15 Feb 2026 | Direct | ||
| Timothy Edward Lee | IVVD | Common Stock | Options Exercise | 166.8% | 99,000 | 158,344 | 15 Feb 2026 | Direct | ||
| Timothy Edward Lee | IVVD | Restricted Stock Units | Options Exercise | -49.2% | -99,000 | 102,000 | 15 Feb 2026 | Direct | ||
| Jill Andersen | IVVD | Common Stock | Options Exercise | 195.4% | 165,000 | 249,446 | 15 Feb 2026 | Direct | ||
| Jill Andersen | IVVD | Restricted Stock Units | Options Exercise | -49.2% | -165,000 | 170,000 | 15 Feb 2026 | Direct | ||
| Julie Green | IVVD | Stock Option (Right to Buy) | Award | 675,000 | 675,000 | 29 Jan 2026 | Direct | |||
| Timothy Edward Lee | IVVD | Stock Option (Right to Buy) | Award | 675,000 | 675,000 | 29 Jan 2026 | Direct | |||
| Jill Andersen | IVVD | Stock Option (Right to Buy) | Award | 820,000 | 820,000 | 29 Jan 2026 | Direct | |||
| Robert D. Allen III | IVVD | Stock Option (Right to Buy) | Award | 625,000 | 625,000 | 29 Jan 2026 | Direct | |||
| William E. Duke | IVVD | Stock Option (Right to Buy) | Award | 625,000 | 625,000 | 29 Jan 2026 | Direct | |||
| Kevin F. McLaughlin | IVVD | Common Stock | Purchase | $125,000 | $2.50 | 50,000 | 50,000 | 19 Nov 2025 | Direct | |
| Paul Bolno | IVVD | Stock Option (Right to Buy) | Award | 100,000 | 100,000 | 22 Sep 2025 | Direct | |||
| Timothy Edward Lee | IVVD | Common Stock | Sale | -33.3% | $16,796 | $0.5666 | -29,643 | 59,344 | 19 Aug 2025 | Direct |
| William E. Duke | IVVD | Common Stock | Sale | -37.5% | $16,796 | $0.5666 | -29,643 | 49,344 | 19 Aug 2025 | Direct |
| Julie Green | IVVD | Common Stock | Sale | -37.5% | $16,796 | $0.5666 | -29,643 | 49,344 | 19 Aug 2025 | Direct |
| Jill Andersen | IVVD | Common Stock | Sale | -36.9% | $27,991 | $0.5666 | -49,402 | 84,446 | 19 Aug 2025 | Direct |
| Robert D. Allen III | IVVD | Common Stock | Sale | -34.1% | $15,536 | $0.5666 | -27,420 | 53,068 | 19 Aug 2025 | Direct |
| Timothy Edward Lee | IVVD | Common Stock | Sale | -18.4% | $13,012 | $0.6502 | -20,013 | 88,987 | 18 Aug 2025 | Direct |
| William E. Duke | IVVD | Common Stock | Sale | -20.2% | $13,012 | $0.6502 | -20,013 | 78,987 | 18 Aug 2025 | Direct |
| Julie Green | IVVD | Common Stock | Sale | -20.2% | $13,012 | $0.6502 | -20,013 | 78,987 | 18 Aug 2025 | Direct |
| Jill Andersen | IVVD | Common Stock | Sale | -20% | $21,685 | $0.6502 | -33,352 | 133,848 | 18 Aug 2025 | Direct |
| Robert D. Allen III | IVVD | Common Stock | Sale | -18.7% | $12,036 | $0.6502 | -18,512 | 80,488 | 18 Aug 2025 | Direct |
| Timothy Edward Lee | IVVD | Common Stock | Options Exercise | 990% | 99,000 | 109,000 | 15 Aug 2025 | Direct | ||
| Timothy Edward Lee | IVVD | Restricted Stock Units | Options Exercise | -33% | -99,000 | 201,000 | 15 Aug 2025 | Direct | ||
| William E. Duke | IVVD | Common Stock | Options Exercise | 99,000 | 99,000 | 15 Aug 2025 | Direct | |||
| William E. Duke | IVVD | Restricted Stock Units | Options Exercise | -33% | -99,000 | 201,000 | 15 Aug 2025 | Direct | ||
| Julie Green | IVVD | Common Stock | Options Exercise | 99,000 | 99,000 | 15 Aug 2025 | Direct | |||
| Julie Green | IVVD | Restricted Stock Units | Options Exercise | -33% | -99,000 | 201,000 | 15 Aug 2025 | Direct |
* marks a reported price that did not pass the local price check.